We are live on ! Find out more
AC

Apella Capital Portfolio holdings

AUM $7.08B
1-Year Est. Return 17.38%
This Fund
S&P 500
This Quarter Est. Return
+7.13%
1 Year Est. Return
+17.38%
3 Year Est. Return
+44.51%
5 Year Est. Return
10 Year Est. Return
AUM
$3.69B
AUM Growth
+$776M
Cap. Flow
+$461M
Cap. Flow %
12.51%
Top 10 Hldgs %
39.13%
Holding
431
New
44
Increased
245
Reduced
109
Closed
7

Sector Composition

Rank Sector Weight
1 Technology 3.27%
2 Financials 1.44%
3 Industrials 0.99%
4 Communication Services 0.83%
5 Healthcare 0.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSVO icon
401
EA Bridgeway Omni Small-Cap Value ETF
BSVO
$2.47B
$214K 0.01%
10,116
DHS icon
402
WisdomTree US High Dividend Fund
DHS
$1.57B
$214K 0.01%
2,192
-57
-3% -$5.35K
FNF icon
403
Fidelity National Financial
FNF
$13.7B
$214K 0.01%
3,712
+27
+0.7% +$1.58K
EW icon
404
Edwards Lifesciences
EW
$51.1B
$213K 0.01%
+2,778
New +$207K
COF icon
405
Capital One
COF
$136B
$213K 0.01%
+976
New +$182K
MTB icon
406
M&T Bank
MTB
$36.6B
$209K 0.01%
+1,043
New +$184K
BXMX
407
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
$209K 0.01%
15,035
VONV icon
408
Vanguard Russell 1000 Value ETF
VONV
$21B
$207K 0.01%
+2,408
New +$196K
VHT icon
409
Vanguard Health Care ETF
VHT
$18.3B
$204K 0.01%
825
-92
-10% -$22.7K
FISV
410
Fiserv Inc
FISV
$28.9B
$204K 0.01%
1,176
-78
-6% -$14.1K
AMAT icon
411
Applied Materials
AMAT
$431B
$202K 0.01%
+1,058
New +$168K
PRU icon
412
Prudential Financial
PRU
$41B
$202K 0.01%
1,895
-110
-5% -$11.4K
SCHP icon
413
Schwab US TIPS ETF
SCHP
$16.3B
$200K 0.01%
+7,563
New +$200K
PFO
414
Flaherty & Crumrine Preferred and Income Opportunity Fund
PFO
$120M
$139K ﹤0.01%
15,066
ESBA icon
415
Empire State Realty Series ES
ESBA
$1.35B
$135K ﹤0.01%
17,206
XERS icon
416
Xeris Biopharma Holdings
XERS
$1.42B
$47K ﹤0.01%
10,000
PGEN icon
417
Precigen
PGEN
$2.46B
$46.1K ﹤0.01%
28,985
OMER icon
418
Omeros
OMER
$931M
$44K ﹤0.01%
14,288
MPT
419
Medical Properties Trust
MPT
$2.75B
$42.3K ﹤0.01%
+10,043
New +$49.6K
NERV icon
420
Minerva Neurosciences
NERV
$193M
$34.3K ﹤0.01%
20,939
+314
+2% +$513
PLG
421
Platinum Group Metals
PLG
$187M
$31.5K ﹤0.01%
+20,300
New +$27.2K
SLI
422
Standard Lithium
SLI
$549M
$22.7K ﹤0.01%
10,000
MPT
423
PUT
Medical Properties Trust
MPT
$2.75B
$22.1K ﹤0.01%
12,700
CGTX icon
424
Cognition Therapeutics
CGTX
$94M
$6.48K ﹤0.01%
11,200
BANC icon
425
Banc of California
BANC
$3.08B
-23,065
Closed -$301K

Similar funds

Apella Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Apella Capital held 431 positions worth $3.69B, up 27% from $2.91B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Apella Capital deployed $461M of net new capital in Q2 2025, opening 44 new positions and adding to 245 existing holdings. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 145,736 shares worth $11M.

By sector, the portfolio is most concentrated in Technology at 3.3% of assets, up from 3% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $15M trimmed.

  • Apella Capital's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 145,736 shares worth $11M.
  • Apella Capital added most to Dimensional Short-Duration Fixed Income ETF in Q2 2025, an estimated $33.4M increase.
  • Apella Capital's biggest Q2 2025 reduction was Vanguard Total International Bond ETF, cutting an estimated $15M.
  • Apella Capital fully exited Global X Cybersecurity ETF in Q2 2025, selling an estimated $694K.
  • Apella Capital's ten largest holdings make up 39% of its $3.69B portfolio in Q2 2025.
  • Apella Capital opened 44 new positions and closed 7 in Q2 2025.
  • Apella Capital's portfolio value rose 27% quarter-over-quarter to $3.69B.

Based on Apella Capital's 13F filing for Q2 2025, filed 8 Jul 2025.